26 Jun 2015 17:16
FOR RELEASE ON 26 JUNE 2015
Allied Minds plc (the "Company" or the "Group")
Director / PDMR Shareholding
Allied Minds plc, an innovative U.S.-focused science and technology development and commercialisation company, announces that it received notification on 25 June 2015 that Omar Amirana, MD, Senior Vice President of Life Sciences, a person discharging managerial responsibility ("PDMR"), exercised options on 25 June 2015 over the Company's ordinary shares of one pence each ("Ordinary Shares") as set out below:
Grant Date | Option price | Number of Ordinary Shares | Shareplan |
18 May 2012 | $1.775455 | 500,000 | Allied Minds 2008 Stock Option/Issuance Plan |
Omar Amirana subsequently sold 500,000 Ordinary Shares on the London Stock Exchange (the "LSE") on 25 June 2015, at a price per share of £5.50.
As a result of the above transactions, Omar Amirana's total remaining interests in the Company's Ordinary Shares are the following: (i) 1,040,000 options over Ordinary Shares issued under the Allied Minds 2008 Stock Option/Issuance Plan, and (ii) 320,246 Restricted Share Units issued under the Allied Minds 2014 Long Term Incentive Plan.
This announcement relates to transactions notified in accordance with Disclosure and Transparency Rule ("DTR") 3.1.2R and is given in fulfilment of the obligation under DTR 3.1.4(1)(a).
About Allied Minds
Allied Minds (LSE: ALM) is an innovative U.S. science and technology development and commercialization company. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on innovative technologies developed at leading U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. More information about the Boston-based company can be found at www.alliedminds.com.
For further information, please contact:
Allied Minds plc +1 (617) 419-1800
Michael S. Turner, Company Secretary